In the United States, ALLERGAN, which makes Botox wrinkle treatment, has made an unsolicited $3.2 bn cash takeover bid for US company INAMED, a maker of breast implants and obesity treatments, 16% more than the March 2005 bid from MEDICIS PHARMACEUTICAL ($2.8 mil).